Faheem Hasnain, President & CEO, Director at Receptos, holds 5.16M shares in Gossamer Bio (Ticker: GOSS), holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX), holds 55.00K shares in Nuvation Bio (Ticker: NUVB). Most recently, Faheem Hasnain Sold ― shares of Gossamer Bio on Mar 28, 2024 for an estimated value of 26.65K.
Faheem Hasnain latest transaction was an Informative Sell of $26.65K.
What was Faheem Hasnain's most profitable transaction?
Faheem Hasnain’s most profitable transaction was an Informative Buy of GOSS stock on October 14, 2020. The return on the trade was 44.80%.
What is Faheem Hasnain's role in Receptos?
Faheem Hasnain's role in Receptos is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.